Teclistamab, sold under the brand name Tecvayli, is a human bispecific monoclonal antibody used for the treatment of relapsed and refractory multiple myeloma. From Wikipedia
Kathryn Oddie, diagnosed with incurable blood cancer in 2000, achieved her first remission in 2021 and is now raising awareness about the importance of research into new treatments.
